News | September 12, 2024
AGC and Medinet sign agreement for cell therapy CDMO business
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
ALS patients experience neuroinflammation and rapid neurodegeneration
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
More than 10 oral and mini-oral presentations span Pfizer’s extensive Oncology portfolio of approved and investigational therapies
The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
Subscribe To Our Newsletter & Stay Updated
